# BEZ235 Trial in Patients With Advanced Endometrial Carcinoma

> **NCT01290406** · PHASE2 · WITHDRAWN · sponsor: **Novartis Pharmaceuticals**

## Conditions studied

- Endometrial Cancer

## Interventions

- **DRUG:** BEZ235

## Key facts

- **NCT ID:** NCT01290406
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2012-03
- **Primary completion:** 2014-09
- **Final completion:** 2017-12
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2012-06-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01290406

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01290406, "BEZ235 Trial in Patients With Advanced Endometrial Carcinoma". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01290406. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*